Diabetes Mellitus, Type 2

Showing NaN - NaN of 183

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Empagliflozin, Metformin)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Toluca Lake, California
  • +101 more
Oct 9, 2023

Diabetes, Type 2, Peripheral Arterial Disease Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Recruiting
  • Diabetes Mellitus, Type 2
  • Peripheral Arterial Disease
  • Birmingham, Alabama
  • +179 more
Jan 23, 2023

Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)

Recruiting
  • Obesity
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +73 more
Jan 24, 2023

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +393 more
Jan 17, 2023

Diabetes, Type 2, Chronic Kidney Disease Trial in Worldwide (Semaglutide, Placebo (Semaglutide))

Recruiting
  • Diabetes Mellitus, Type 2
  • Chronic Kidney Disease
  • Tucson, Arizona
  • +33 more
Jan 17, 2023

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Placebo insulin icodec, Insulin degludec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +3 more
  • Guntersville, Alabama
  • +91 more
Nov 11, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin Glargine 100U/mL, Insulin Degludec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +3 more
  • Birmingham, Alabama
  • +178 more
Nov 3, 2022

Diabetes, Type 2 Trial in Worldwide (Linagliptin, Empagliflozin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +82 more
Aug 23, 2022

Diabetes, Type 2 Trial in Worldwide (Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Canagliflozin 100 mg
  • +2 more
  • Little Rock, Arkansas
  • +121 more
Aug 18, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, empagliflozin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +105 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Lancaster, California
  • +104 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +107 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, sitagliptin, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +241 more
Jul 11, 2022

Diabetes, Type 2 Trial in Worldwide (Metformin DR, Metformin IR, Metformin DR Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Metformin DR
  • +3 more
  • Glendale, Arizona
  • +86 more
Jun 7, 2022

Diabetes, Type 2 Trial in Worldwide (Oral semaglutide)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • Buena Park, California
  • +177 more
Mar 31, 2022

Diabetes, Type 2 Trial in Worldwide (NNC0480-0389, Semaglutide, Placebo (NNC080-0389))

Recruiting
  • Diabetes Mellitus, Type 2
  • Buena Park, California
  • +95 more
Mar 31, 2022

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (Eversense® CGM system)

Active, not recruiting
  • Diabetes Mellitus
  • +2 more
  • Eversense® CGM system
  • Newport Beach, California
  • +16 more
Mar 31, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin Icodec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin Icodec
  • Buena Park, California
  • +71 more
Mar 29, 2022

Diabetes, Type 2 Trial in Worldwide (IcoSema, Insulin glargine, insulin aspart)

Recruiting
  • Diabetes Mellitus, Type 2
  • La Jolla, California
  • +100 more
Mar 24, 2022

Diabetes, Type 2 Trial in Worldwide (Alogliptin Benzoate, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Alogliptin Benzoate
  • Placebo
  • Little Rock, Arkansas
  • +54 more
Mar 14, 2022

Obesity, Hypertension, Diabetes, Type 2 Trial in United States (Overstitch)

Completed
  • Obesity
  • +2 more
  • Overstitch
  • Orlando, Florida
  • +8 more
Mar 14, 2022

Diabetes, Type 2 Trial in United States (Semaglutide 2.4 mg, Cagrilintide 2.4 mg, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide 2.4 mg
  • +3 more
  • Birmingham, Alabama
  • +17 more
Mar 14, 2022

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Montgomery, Alabama
  • +444 more
Mar 11, 2022

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Completed
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +128 more
Feb 14, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin glargine
  • Anniston, Alabama
  • +228 more
Jan 6, 2022